Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals.

Bibliographic Details
Title: Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals.
Authors: Molinos-Albert, Luis M.1 lmmolinos@irsicaixa.es, Carrillo, Jorge1 jcarrillo@irsicaixa.es, Curriu, Marta1 marta.curriu@gmail.com, Rodriguez de la Concepción, Maria L.1 mlrodriguez@irsicaixa.es, Marfil, Silvia1 smarfil@irsicaixa.es, García, Elisabet1 egarcia@irsicaixa.es, Clotet, Bonaventura1,2 bclotet@irsicaixa.es, Blanco, Julià1,2 jblanco@irsicaixa.es
Source: Retrovirology. 2014, Vol. 11 Issue 1, p1-21. 21p.
Subject Terms: *GLYCOPROTEINS, *EPITOPES, *HIV-positive persons, *FLOW cytometry, *ENZYME-linked immunosorbent assay, *HIV, *MEMBRANE glycoproteins
Abstract: Background The MPER region of the HIV-1 envelope glycoprotein gp41 is targeted by broadly neutralizing antibodies. However, the localization of this epitope in a hydrophobic environment seems to hamper the elicitation of these antibodies in HIV infected individuals. We have quantified and characterized anti-MPER antibodies by ELISA and by flow cytometry using a collection of mini gp41-derived proteins expressed on the surface of 293T 2 cells. Longitudinal plasma samples from 35 HIV-1 infected individuals were assayed for MPER recognition and MPER-dependent neutralizing capacity using HIV-2 viruses engrafted with HIV-1 MPER sequences. Results Miniproteins devoid of the cysteine loop of gp41 exposed the MPER on 293T cell membrane. Anti-MPER antibodies were identified in most individuals and were stable when analyzed in longitudinal samples. The magnitude of the responses was strongly correlated with the global response to the HIV-1 envelope glycoprotein, suggesting no specific limitation for anti- MPER antibodies. Peptide mapping showed poor recognition of the C-terminal MPER moiety and a wide presence of antibodies against the 2F5 epitope. However, antibody titers failed to correlate with 2F5-blocking activity and, more importantly, with the specific neutralization of HIV-2 chimeric viruses bearing the HIV-1 MPER sequence; suggesting a strong functional heterogeneity in anti-MPER humoral responses. Conclusions Anti-MPER antibodies can be detected in the vast majority of HIV-1 infected individuals and are generated in the context of the global anti-Env response. However, the neutralizing capacity is heterogeneous suggesting that eliciting neutralizing anti-MPER antibodies by immunization might require refinement of immunogens to skip nonneutralizing responses. [ABSTRACT FROM AUTHOR]
Copyright of Retrovirology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
More Details
ISSN:17424690
DOI:10.1186/1742-4690-11-44
Published in:Retrovirology
Language:English